Report

  1. Home
  2. Discounted reports

API Intermediate Market By Type (Bulk Drug Intermediates, Chemical Intermediates), By Application (Analgesics, Anti-Infective Drugs, Antidiabetic Drugs, Cardiovascular Drugs, Anticancer Drugs, Others), By End User (Biotech and Pharmaceutical Companies, CMO, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Market Report I 2023-06-01 I 390 Pages I Allied Market Research
Discounted by 10% to 2024-11-15

The API Intermediate Market was valued for $139,421.09 million in 2022 and is estimated to reach $284,953.44 million by 2032, exhibiting a CAGR of 7.4% from 2023 to 2032.
Active pharmaceutical ingredients (APIs) are substances or combination of substances used to manufacture a drug product. The raw material used in formulation of active pharmaceutical ingredients is known as API intermediates. API intermediates are material produced in the process of manufacturing of API. There are two types of API intermediates, which includes chemical intermediates and bulk drug intermediates. A bulk drug intermediate refers to a chemical substance or compound that is produced during the manufacturing process of a pharmaceutical drug. A chemical intermediate, on the other hand, is a compound or substance that is produced during the synthesis or production of various chemicals, including pharmaceuticals, agrochemicals, dyes, polymers, and other industrial products.
The growth of the API intermediates market is driven by rise in the prevalence of chronic diseases and increase in number of geriatric populations. APIs and intermediates possess application in high-quality drugs used for the treatment of diseases, such as oncology, cardiology, central nervous system (CNS) and neurology, orthopedic, pulmonology, gastroenterology, nephrology, ophthalmology, and endocrinology. APIs and intermediates can potentially create a more sustainable healthcare system by introducing more innovative products. Thus, rise in number of populations suffering from chronic diseases, such as cardiac diseases, is anticipated to fuel the demand for API intermediates and boosts the market growth. For instance, according to the British Heart Foundation, around 1,139,140 people were suffering from heart and circulatory diseases in the UK in 2022. As per the same source, around 650,681 male and 488,320 female population were suffering from heart and circulatory diseases in the UK in 2022.
Moreover, according to the American Heart Association, 244.1 million people were estimated to be living with ischemic heart disease (IHD) in 2020. As per the same source, IHD was more prevalent in males than in females, 141.0 and 103.1 million people, respectively.
In addition, the American Cancer Society reported that, around 1,918,030 new cases of cancer detected in the U.S. in 2022. Moreover, World Cancer Research Fund International, (WCRFI), reported that around 18.1 million new cancer cases were detected in 2020 globally. Furthermore, rise in number of populations suffering from pulmonary and gastrointestinal disorders is expected to increase the demand for API intermediates and fuels the growth of the market. The global initiative for chronic obstructive lung disease (GOLD), in 2022, reported that 200 million people had chronic obstructive pulmonary disease (COPD), of which about 3.2 million die each year, making it the third-leading cause of death globally. In addition, as per the same source, asthma is one of the most common non-communicable diseases, globally affecting 262 million people in 2022.
High presence of companies who manufacture API intermediates is anticipated to boost the growth of the market. For instance, Shubham Specialty Products, Akums Drugs & Pharmaceuticals Ltd., Vasoya Industrial Pvt. Lmt., Corey Organics, Icon Pharma Chem, and SLN Pharmachem are some of the key market players who manufacture API intermediates.
However, the high cost associated with the acquisition of biopharmaceutical drugs is a major factor hampering the growth of global API intermediates market. Also, the high cAPItal investment required to produce API intermediates is expected to restrain the market growth.
On the contrary, rise in initiative taken by government of different countries such as India, China, Japan, and others, for development of healthcare infrastructure and increase in expenditure for development of API intermediates manufacturing units are anticipated to offer remunerative opportunities for the expansion of the market during the forecast period.
The global API intermediates market is segmented into type, application, end user, and region. By type, the market is divided into bulk drug intermediates and chemical intermediates. On the basis of application, the market is divided into analgesics, anti-infective drugs, antidiabetic drugs, cardiovascular drugs, anticancer drugs and others. By end user, the market is segmented into biotech & pharmaceutical companies, CMO and research laboratories. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global API intermediates market include Anyang General Chemical Co., Ltd., Sandoo Pharmaceuticals, Evonik Industries AG, Shree Ganesh Remedies Limited, Pfizer, Cambrex Corporation, Zeal & Innovation in Medicine, cation pharma, Hikal Ltd., and Espee.
Key Benefits For Stakeholders
-This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the API intermediate market analysis from 2022 to 2032 to identify the prevailing API intermediate market opportunities.
-The market research is offered along with information related to key drivers, restraints, and opportunities.
-Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
-In-depth analysis of the API intermediate market segmentation assists to determine the prevailing market opportunities.
-Major countries in each region are mapped according to their revenue contribution to the global market.
-Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
-The report includes the analysis of the regional as well as global APIintermediate market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
- Bulk Drug Intermediates
- Chemical Intermediates
By Application
- Analgesics
- Anti-Infective Drugs
- Antidiabetic Drugs
- Cardiovascular Drugs
- Anticancer Drugs
- Others
By End User
- Biotech and Pharmaceutical Companies
- CMO
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Anyang General Chemical Co., Ltd.
- Cambrex Corporation
- Cation Pharma
- Espee
- Evonik Industries AG.
- Hikal Ltd
- Pfizer Inc.
- Sandoo Pharmaceuticals
- Shree Ganesh Remedies Limited
- Zeal & Innovation in Medicine

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.3.1. Low bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Low intensity of rivalry
3.3.5. Low bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of chronic disease
3.4.1.2. High presence of market players
3.4.1.3. Surge in number of geriatric populations

3.4.2. Restraints
3.4.2.1. Stringent government rules

3.4.3. Opportunities
3.4.3.1. Rapid growth of biopharmaceutical industry
3.4.3.2. Increase in adoptions of key strategies by market players.

3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: API INTERMEDIATE MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Bulk Drug Intermediates
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Chemical Intermediates
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: API INTERMEDIATE MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Analgesics
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Anti-Infective Drugs
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Antidiabetic Drugs
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Cardiovascular Drugs
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
5.6. Anticancer Drugs
5.6.1. Key market trends, growth factors and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis by country
5.7. Others
5.7.1. Key market trends, growth factors and opportunities
5.7.2. Market size and forecast, by region
5.7.3. Market share analysis by country
CHAPTER 6: API INTERMEDIATE MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Biotech and Pharmaceutical Companies
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. CMO
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: API INTERMEDIATE MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Type
7.2.3. Market size and forecast, by Application
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Type
7.2.5.1.3. Market size and forecast, by Application
7.2.5.1.4. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Type
7.2.5.2.3. Market size and forecast, by Application
7.2.5.2.4. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Type
7.2.5.3.3. Market size and forecast, by Application
7.2.5.3.4. Market size and forecast, by End User
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Type
7.3.3. Market size and forecast, by Application
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Type
7.3.5.1.3. Market size and forecast, by Application
7.3.5.1.4. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Type
7.3.5.2.3. Market size and forecast, by Application
7.3.5.2.4. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Type
7.3.5.3.3. Market size and forecast, by Application
7.3.5.3.4. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Type
7.3.5.4.3. Market size and forecast, by Application
7.3.5.4.4. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Type
7.3.5.5.3. Market size and forecast, by Application
7.3.5.5.4. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Type
7.3.5.6.3. Market size and forecast, by Application
7.3.5.6.4. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Type
7.4.3. Market size and forecast, by Application
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Type
7.4.5.1.3. Market size and forecast, by Application
7.4.5.1.4. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Type
7.4.5.2.3. Market size and forecast, by Application
7.4.5.2.4. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Type
7.4.5.3.3. Market size and forecast, by Application
7.4.5.3.4. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Type
7.4.5.4.3. Market size and forecast, by Application
7.4.5.4.4. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Type
7.4.5.5.3. Market size and forecast, by Application
7.4.5.5.4. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Type
7.4.5.6.3. Market size and forecast, by Application
7.4.5.6.4. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Type
7.5.3. Market size and forecast, by Application
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Type
7.5.5.1.3. Market size and forecast, by Application
7.5.5.1.4. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Type
7.5.5.2.3. Market size and forecast, by Application
7.5.5.2.4. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Type
7.5.5.3.3. Market size and forecast, by Application
7.5.5.3.4. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Type
7.5.5.4.3. Market size and forecast, by Application
7.5.5.4.4. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Anyang General Chemical Co., Ltd.
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.2. Sandoo Pharmaceuticals
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.3. Evonik Industries AG.
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. Shree Ganesh Remedies Limited
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.5. Cambrex Corporation
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Key strategic moves and developments
9.6. Zeal & Innovation in Medicine
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.7. Cation Pharma
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. Espee
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.9. Hikal Ltd
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.10. Pfizer Inc.
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance

LIST OF TABLES
TABLE 01. GLOBAL API INTERMEDIATE MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 02. API INTERMEDIATE MARKET FOR BULK DRUG INTERMEDIATES, BY REGION, 2022-2032 ($MILLION)
TABLE 03. API INTERMEDIATE MARKET FOR CHEMICAL INTERMEDIATES, BY REGION, 2022-2032 ($MILLION)
TABLE 04. GLOBAL API INTERMEDIATE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 05. API INTERMEDIATE MARKET FOR ANALGESICS, BY REGION, 2022-2032 ($MILLION)
TABLE 06. API INTERMEDIATE MARKET FOR ANTI-INFECTIVE DRUGS, BY REGION, 2022-2032 ($MILLION)
TABLE 07. API INTERMEDIATE MARKET FOR ANTIDIABETIC DRUGS, BY REGION, 2022-2032 ($MILLION)
TABLE 08. API INTERMEDIATE MARKET FOR CARDIOVASCULAR DRUGS, BY REGION, 2022-2032 ($MILLION)
TABLE 09. API INTERMEDIATE MARKET FOR ANTICANCER DRUGS, BY REGION, 2022-2032 ($MILLION)
TABLE 10. API INTERMEDIATE MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 11. GLOBAL API INTERMEDIATE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 12. API INTERMEDIATE MARKET FOR BIOTECH AND PHARMACEUTICAL COMPANIES, BY REGION, 2022-2032 ($MILLION)
TABLE 13. API INTERMEDIATE MARKET FOR CMO, BY REGION, 2022-2032 ($MILLION)
TABLE 14. API INTERMEDIATE MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 15. API INTERMEDIATE MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 16. NORTH AMERICA API INTERMEDIATE MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 17. NORTH AMERICA API INTERMEDIATE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 18. NORTH AMERICA API INTERMEDIATE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 19. NORTH AMERICA API INTERMEDIATE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 20. U.S. API INTERMEDIATE MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 21. U.S. API INTERMEDIATE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 22. U.S. API INTERMEDIATE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 23. CANADA API INTERMEDIATE MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 24. CANADA API INTERMEDIATE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 25. CANADA API INTERMEDIATE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 26. MEXICO API INTERMEDIATE MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 27. MEXICO API INTERMEDIATE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 28. MEXICO API INTERMEDIATE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 29. EUROPE API INTERMEDIATE MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 30. EUROPE API INTERMEDIATE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 31. EUROPE API INTERMEDIATE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 32. EUROPE API INTERMEDIATE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 33. GERMANY API INTERMEDIATE MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 34. GERMANY API INTERMEDIATE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 35. GERMANY API INTERMEDIATE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 36. FRANCE API INTERMEDIATE MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 37. FRANCE API INTERMEDIATE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 38. FRANCE API INTERMEDIATE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 39. UK API INTERMEDIATE MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 40. UK API INTERMEDIATE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 41. UK API INTERMEDIATE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 42. ITALY API INTERMEDIATE MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 43. ITALY API INTERMEDIATE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 44. ITALY API INTERMEDIATE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 45. SPAIN API INTERMEDIATE MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 46. SPAIN API INTERMEDIATE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 47. SPAIN API INTERMEDIATE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 48. REST OF EUROPE API INTERMEDIATE MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 49. REST OF EUROPE API INTERMEDIATE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 50. REST OF EUROPE API INTERMEDIATE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 51. ASIA-PACIFIC API INTERMEDIATE MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 52. ASIA-PACIFIC API INTERMEDIATE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 53. ASIA-PACIFIC API INTERMEDIATE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 54. ASIA-PACIFIC API INTERMEDIATE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 55. JAPAN API INTERMEDIATE MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 56. JAPAN API INTERMEDIATE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 57. JAPAN API INTERMEDIATE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 58. CHINA API INTERMEDIATE MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 59. CHINA API INTERMEDIATE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 60. CHINA API INTERMEDIATE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 61. INDIA API INTERMEDIATE MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 62. INDIA API INTERMEDIATE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 63. INDIA API INTERMEDIATE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 64. AUSTRALIA API INTERMEDIATE MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 65. AUSTRALIA API INTERMEDIATE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 66. AUSTRALIA API INTERMEDIATE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 67. SOUTH KOREA API INTERMEDIATE MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 68. SOUTH KOREA API INTERMEDIATE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 69. SOUTH KOREA API INTERMEDIATE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC API INTERMEDIATE MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC API INTERMEDIATE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC API INTERMEDIATE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 73. LAMEA API INTERMEDIATE MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 74. LAMEA API INTERMEDIATE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 75. LAMEA API INTERMEDIATE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 76. LAMEA API INTERMEDIATE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 77. BRAZIL API INTERMEDIATE MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 78. BRAZIL API INTERMEDIATE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 79. BRAZIL API INTERMEDIATE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 80. SAUDI ARABIA API INTERMEDIATE MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 81. SAUDI ARABIA API INTERMEDIATE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 82. SAUDI ARABIA API INTERMEDIATE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 83. SOUTH AFRICA API INTERMEDIATE MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 84. SOUTH AFRICA API INTERMEDIATE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 85. SOUTH AFRICA API INTERMEDIATE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 86. REST OF LAMEA API INTERMEDIATE MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 87. REST OF LAMEA API INTERMEDIATE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 88. REST OF LAMEA API INTERMEDIATE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 89. ANYANG GENERAL CHEMICAL CO., LTD.: KEY EXECUTIVES
TABLE 90. ANYANG GENERAL CHEMICAL CO., LTD.: COMPANY SNAPSHOT
TABLE 91. ANYANG GENERAL CHEMICAL CO., LTD.: PRODUCT SEGMENTS
TABLE 92. ANYANG GENERAL CHEMICAL CO., LTD.: PRODUCT PORTFOLIO
TABLE 93. SANDOO PHARMACEUTICALS: KEY EXECUTIVES
TABLE 94. SANDOO PHARMACEUTICALS: COMPANY SNAPSHOT
TABLE 95. SANDOO PHARMACEUTICALS: PRODUCT SEGMENTS
TABLE 96. SANDOO PHARMACEUTICALS: PRODUCT PORTFOLIO
TABLE 97. EVONIK INDUSTRIES AG.: KEY EXECUTIVES
TABLE 98. EVONIK INDUSTRIES AG.: COMPANY SNAPSHOT
TABLE 99. EVONIK INDUSTRIES AG.: PRODUCT SEGMENTS
TABLE 100. EVONIK INDUSTRIES AG.: PRODUCT PORTFOLIO
TABLE 101. SHREE GANESH REMEDIES LIMITED: KEY EXECUTIVES
TABLE 102. SHREE GANESH REMEDIES LIMITED: COMPANY SNAPSHOT
TABLE 103. SHREE GANESH REMEDIES LIMITED: PRODUCT SEGMENTS
TABLE 104. SHREE GANESH REMEDIES LIMITED: SERVICE SEGMENTS
TABLE 105. SHREE GANESH REMEDIES LIMITED: PRODUCT PORTFOLIO
TABLE 106. CAMBREX CORPORATION: KEY EXECUTIVES
TABLE 107. CAMBREX CORPORATION: COMPANY SNAPSHOT
TABLE 108. CAMBREX CORPORATION: PRODUCT SEGMENTS
TABLE 109. CAMBREX CORPORATION: SERVICE SEGMENTS
TABLE 110. CAMBREX CORPORATION: PRODUCT PORTFOLIO
TABLE 111. CAMBREX CORPORATION: KEY STRATERGIES
TABLE 112. ZEAL & INNOVATION IN MEDICINE: KEY EXECUTIVES
TABLE 113. ZEAL & INNOVATION IN MEDICINE: COMPANY SNAPSHOT
TABLE 114. ZEAL & INNOVATION IN MEDICINE: PRODUCT SEGMENTS
TABLE 115. ZEAL & INNOVATION IN MEDICINE: PRODUCT PORTFOLIO
TABLE 116. CATION PHARMA: KEY EXECUTIVES
TABLE 117. CATION PHARMA: COMPANY SNAPSHOT
TABLE 118. CATION PHARMA: PRODUCT SEGMENTS
TABLE 119. CATION PHARMA: PRODUCT PORTFOLIO
TABLE 120. ESPEE: KEY EXECUTIVES
TABLE 121. ESPEE: COMPANY SNAPSHOT
TABLE 122. ESPEE: PRODUCT SEGMENTS
TABLE 123. ESPEE: PRODUCT PORTFOLIO
TABLE 124. HIKAL LTD: KEY EXECUTIVES
TABLE 125. HIKAL LTD: COMPANY SNAPSHOT
TABLE 126. HIKAL LTD: PRODUCT SEGMENTS
TABLE 127. HIKAL LTD: PRODUCT PORTFOLIO
TABLE 128. PFIZER INC.: KEY EXECUTIVES
TABLE 129. PFIZER INC.: COMPANY SNAPSHOT
TABLE 130. PFIZER INC.: PRODUCT SEGMENTS
TABLE 131. PFIZER INC.: PRODUCT PORTFOLIO

LIST OF FIGURES
FIGURE 01. API INTERMEDIATE MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF API INTERMEDIATE MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN API INTERMEDIATE MARKET (2023-2032)
FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 05. LOW THREAT OF NEW ENTRANTS
FIGURE 06. LOW THREAT OF SUBSTITUTES
FIGURE 07. LOW INTENSITY OF RIVALRY
FIGURE 08. LOW BARGAINING POWER OF BUYERS
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALAPI INTERMEDIATE MARKET
FIGURE 09. API INTERMEDIATE MARKET, BY TYPE, 2022(%)
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF API INTERMEDIATE MARKET FOR BULK DRUG INTERMEDIATES, BY COUNTRY 2022 AND 2032(%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF API INTERMEDIATE MARKET FOR CHEMICAL INTERMEDIATES, BY COUNTRY 2022 AND 2032(%)
FIGURE 12. API INTERMEDIATE MARKET, BY APPLICATION, 2022(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF API INTERMEDIATE MARKET FOR ANALGESICS, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF API INTERMEDIATE MARKET FOR ANTI-INFECTIVE DRUGS, BY COUNTRY 2022 AND 2032(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF API INTERMEDIATE MARKET FOR ANTIDIABETIC DRUGS, BY COUNTRY 2022 AND 2032(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF API INTERMEDIATE MARKET FOR CARDIOVASCULAR DRUGS, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF API INTERMEDIATE MARKET FOR ANTICANCER DRUGS, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF API INTERMEDIATE MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 19. API INTERMEDIATE MARKET, BY END USER, 2022(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF API INTERMEDIATE MARKET FOR BIOTECH AND PHARMACEUTICAL COMPANIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF API INTERMEDIATE MARKET FOR CMO, BY COUNTRY 2022 AND 2032(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF API INTERMEDIATE MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 23. API INTERMEDIATE MARKET BY REGION, 2022
FIGURE 24. U.S. API INTERMEDIATE MARKET, 2022-2032 ($MILLION)
FIGURE 25. CANADA API INTERMEDIATE MARKET, 2022-2032 ($MILLION)
FIGURE 26. MEXICO API INTERMEDIATE MARKET, 2022-2032 ($MILLION)
FIGURE 27. GERMANY API INTERMEDIATE MARKET, 2022-2032 ($MILLION)
FIGURE 28. FRANCE API INTERMEDIATE MARKET, 2022-2032 ($MILLION)
FIGURE 29. UK API INTERMEDIATE MARKET, 2022-2032 ($MILLION)
FIGURE 30. ITALY API INTERMEDIATE MARKET, 2022-2032 ($MILLION)
FIGURE 31. SPAIN API INTERMEDIATE MARKET, 2022-2032 ($MILLION)
FIGURE 32. REST OF EUROPE API INTERMEDIATE MARKET, 2022-2032 ($MILLION)
FIGURE 33. JAPAN API INTERMEDIATE MARKET, 2022-2032 ($MILLION)
FIGURE 34. CHINA API INTERMEDIATE MARKET, 2022-2032 ($MILLION)
FIGURE 35. INDIA API INTERMEDIATE MARKET, 2022-2032 ($MILLION)
FIGURE 36. AUSTRALIA API INTERMEDIATE MARKET, 2022-2032 ($MILLION)
FIGURE 37. SOUTH KOREA API INTERMEDIATE MARKET, 2022-2032 ($MILLION)
FIGURE 38. REST OF ASIA-PACIFIC API INTERMEDIATE MARKET, 2022-2032 ($MILLION)
FIGURE 39. BRAZIL API INTERMEDIATE MARKET, 2022-2032 ($MILLION)
FIGURE 40. SAUDI ARABIA API INTERMEDIATE MARKET, 2022-2032 ($MILLION)
FIGURE 41. SOUTH AFRICA API INTERMEDIATE MARKET, 2022-2032 ($MILLION)
FIGURE 42. REST OF LAMEA API INTERMEDIATE MARKET, 2022-2032 ($MILLION)
FIGURE 43. TOP WINNING STRATEGIES, BY YEAR
FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 46. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 47. COMPETITIVE DASHBOARD
FIGURE 48. COMPETITIVE HEATMAP: API INTERMEDIATE MARKET
FIGURE 49. TOP PLAYER POSITIONING, 2022
FIGURE 50. EVONIK INDUSTRIES AG: NET SALES, 2020-2022 ($MILLION)
FIGURE 51. EVONIK INDUSTRIES AG: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 52. EVONIK INDUSTRIES AG: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 53. PFIZER INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 54. PFIZER INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 55. PFIZER INC.: REVENUE SHARE BY REGION, 2022 (%)

  • Not Sure / Need Reassuring
    • Confirm Content

      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages

      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives

      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices

      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts

      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies

      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses

      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License

      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats

      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery

      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges

      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card

      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer

      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security

      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security

      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE
  • $3456.00 $3110.40
  • $5730.00 $5157.00
  • $9600.00 $8640.00
  • ADD TO BASKET
  • BUY NOW